发明授权
- 专利标题： Deazapurines and uses thereof
- 专利标题（中）： 脱氮嘌呤及其用途
-
申请号： US10500840申请日： 2003-01-07
-
公开(公告)号： US07314936B2公开(公告)日： 2008-01-01
- 发明人: Jane Daun , Heather A. Davis , Bruce DeCosta , Fabian Gusovsky , Ieharu Hishinuma , Yimin Jiang , Toshihiko Kaneko , Kouichi Kikuchi , Seiichi Kobayashi , André Lescarbeau , Xiang-Yi Li , Kenzo Muramoto , Norihito Ohi , Marc Pesant , Boris M. Seletsky , Motohiro Soejima , Mark Spyvee , Lynda Tremblay , Ye Yao , Hiromitsu Yokohama , Yan (Janet) Zhao , Wanjun Zheng
- 申请人： Jane Daun , Heather A. Davis , Bruce DeCosta , Fabian Gusovsky , Ieharu Hishinuma , Yimin Jiang , Toshihiko Kaneko , Kouichi Kikuchi , Seiichi Kobayashi , André Lescarbeau , Xiang-Yi Li , Kenzo Muramoto , Norihito Ohi , Marc Pesant , Boris M. Seletsky , Motohiro Soejima , Mark Spyvee , Lynda Tremblay , Ye Yao , Hiromitsu Yokohama , Yan (Janet) Zhao , Wanjun Zheng
- 申请人地址： JP Tokyo
- 专利权人： Eisai Co., Ltd.
- 当前专利权人： Eisai Co., Ltd.
- 当前专利权人地址： JP Tokyo
- 代理机构： Myers Bigel Sibley & Sajovec, PA
- 国际申请： PCT/US03/00366 WO 20030107
- 国际公布： WO03/057696 WO 20030717
- 主分类号： C07D498/02
- IPC分类号： C07D498/02 ; C07D513/02 ; C07D515/02 ; C07D471/02
摘要：
The present invention provides compounds having formula (I), wherein R1, R2, R3 and n are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof in the treatment of inflammatory or autoimmune and proliferative disorders and as inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction generally
公开/授权文献
- US20050124649A1 Deazapurines and uses thereof 公开/授权日：2005-06-09
信息查询
